We are dedicated to providing resources to patients, practicing clinicians, and all individuals concerned w/ improving the care of patients with kidney disease.

Autoimmune glomerulonephritis = shared injury pathways 🔬 Complement, IL-17/IL-23, Fc receptors & interferon drive renal damage across lupus, IgA, & ANCA diseases. 🧩 Biopsy + multiomics may guide personalized therapy. #Nephrology #AutoimmuneDisease #GN pubmed.ncbi.nlm.nih.gov/4113…
4
📈 In IgA nephropathy, a high Cholesterol-HDL-Glucose (CHG) index > 5.29 predicts poorer kidney survival. ⚠️ Patients showed an 84% greater risk of renal decline. Metabolic imbalance = worse renal outcomes. #IgAN #Nephrology #MetabolicSyndrome pubmed.ncbi.nlm.nih.gov/4110…
8
In IgA nephropathy, a higher neutrophil-to-lymphocyte ratio (NLR) predicts early kidney decline. 🩸 Inflammation marker tied to lower eGFR & worse clinical profile. 📊 NLR could serve as a simple risk tool for IgAN progression. #IgAN #Nephrology #eGFR pubmed.ncbi.nlm.nih.gov/4113…
26
A new multi-modality ultrasound model integrates grayscale, color Doppler & SWE to assess renal fibrosis in CKD. 🎯 AUC = 0.88 💡 Non-invasive, accurate, & ready for personalized kidney care. #CKD #Radiomics #Ultrasound #Nephrology #MedicalResearch pubmed.ncbi.nlm.nih.gov/4113…
13
Today we celebrate the people behind the progress.
15
High glucose triggers O-GlcNAcylation of ACSL4, driving ferroptosis in kidney cells 🧬 Knocking down OGT protected against renal damage in diabetic nephropathy models. 🔍 A new path toward targeted kidney protection. #Nephrology #KidneyHealth #Ferroptosis pubmed.ncbi.nlm.nih.gov/4113…
14
🧠 New study: Transdermal GFR detects AKI hours earlier than creatinine in cirrhotic mice — with no tubular injury. ⚡ Non-invasive skin sensor = faster, more sensitive kidney monitoring. #AKI #Nephrology #BiomedicalInnovation #LiverDisease pubmed.ncbi.nlm.nih.gov/4113…
7
🩺 New editorial in Br J Hosp Med: “Reducing Therapeutic Nihilism in Chronic Kidney Disease.” CKD deserves proactive, hopeful management — not resignation. Empower patients. Intervene early. Treat boldly. #Nephrology #KidneyHealth #CKD #ClinicalCare ow.ly/bbqw50XhU6W
7
🩺 SPK transplant study (n=307): Early steroid withdrawal ≈ steroid maintenance for rejection risk (26% vs. 29%). Graft survival linked to rejection—not regimen. #Transplant #Nephrology #Endocrinology #ClinicalResearch pubmed.ncbi.nlm.nih.gov/4113…
12
🏃‍♂️💚 New study of 119K+ Americans with Type 2 diabetes shows: Even modest physical activity = big health gains. Inactive → “Good health” ↑ 2.6× with regular movement. Perfection isn’t required—progress matters. #Diabetes #KidneyHealth #CVD pubmed.ncbi.nlm.nih.gov/4113…
22
🚨 New study: UTI rates after kidney transplant vary 0–12.9% across U.S. centers. Risk factors: stent use, longer catheter time, female sex, older age. Better collaboration = fewer post-transplant infections. #Nephrology #KidneyTransplant #UTI pubmed.ncbi.nlm.nih.gov/4113…
9
🧬 Nanoparticle biomolecular coronas may revolutionize cancer detection. Polystyrene & silica NPs with tailored surfaces distinguished healthy vs cancer patients — even specific cancers (ovarian, kidney). Fast, low-cost, blood-based diagnostics ahead! pubmed.ncbi.nlm.nih.gov/4113…
10
🫀 #CAREHKinHF Registry: In 2,558 HF pts at high hyperkalemia risk: • 29% had hyperkalaemia • Only 29% received optimal RASi/MRA • Potassium binder use low (patiromer 9.1%, SZC 5.9%) Hyperkalaemia → ↑ hospitalization risk (HR 1.59). #Nephrology pubmed.ncbi.nlm.nih.gov/4078…
14
🧬 New era in membranous nephropathy research. The NephCure workshop outlines how PLA2R biomarkers can guide precision trial design and accelerate therapy development for MN. #Nephrology #PLA2R #MembranousNephropathy #ClinicalTrials #NephroNet pubmed.ncbi.nlm.nih.gov/4009…
11
#FACTtrial: In DNA-JB9 + Fibrillary Glomerulopathy, Acthar Gel cut proteinuria > 70% at 12 mo (P < 0.02). Adding tacrolimus offered no extra benefit. Acthar Gel alone is an effective antiproteinuric option for this ultra-rare kidney disease. #Nephrology pubmed.ncbi.nlm.nih.gov/4098…
8
🧬 Phase 3 ALIGN trial: Atrasentan cut proteinuria by 36% vs placebo in IgA nephropathy with favorable safety. No cardiac failure or severe edema observed. Promising step toward better outcomes in #IgAN. #Nephrology #KidneyHealth pubmed.ncbi.nlm.nih.gov/3946…
7
🔮 Nefecon Predicted to Delay Kidney Failure in IgA Nephropathy 🧬 🔗 Learn more: pubmed.ncbi.nlm.nih.gov/4023… #IgANephropathy #Nefecon #KidneyHealth #Nephrology #Proteinuria #eGFR #NefIgArd #ChronicKidneyDisease
23
My kidneys wanted to start a band… but they couldn’t agree on the organ-ization.
7
🔬 Biomarkers in IgA Nephropathy: A Step Toward Precision Medicine 🧪 🔗 Read more: pubmed.ncbi.nlm.nih.gov/4008… #IgANephropathy #Biomarkers #KidneyDisease #PrecisionMedicine #Nephrology #GlomerularDisease
3
4